Drugs & TargetsFree Keytruda approved in China for second-line treatment of locally advanced or metastatic ESCC indication June 26, 2020Vol.46 No.26
Drugs & TargetsFree Keytruda receives second biomarker-based indication from FDA, regardless of tumor type June 19, 2020Vol.46 No.25
Drugs & TargetsFree FoundationOne CDx receives FDA approval as companion diagnostic with Keytruda June 19, 2020Vol.46 No.25
Drugs & TargetsFree Lurbinectedin receives accelerated approval by FDA for metastatic SCLC June 19, 2020Vol.46 No.25
Drugs & TargetsFree Gemtuzumab ozogamicin receives extended indication for CD33-positive AML in pediatric patients June 19, 2020Vol.46 No.25
Drugs & TargetsFree City of Hope signs licensing agreement with Scopus BioPharma to develop novel, targeted IO gene therapy June 19, 2020Vol.46 No.25
Drugs & TargetsFree Royal Philips and MD Anderson to facilitate personalized oncology treatments and clinical trial matching based on genomic markers June 19, 2020Vol.46 No.25
Drugs & TargetsFree Isoray, University of Cincinnati physicians company sign research agreement to study head and neck cancers June 19, 2020Vol.46 No.25
Drugs & TargetsFree Nivolumab approved by FDA for esophageal squamous cell carcinoma June 12, 2020Vol.46 No.24
